tradingkey.logo

Bio-Techne Corp

TECH

51.890USD

+1.890+3.78%
終値 06/25, 16:00ET15分遅れの株価
8.13B時価総額
51.45直近12ヶ月PER

Bio-Techne Corp

51.890

+1.890+3.78%
詳細情報 Bio-Techne Corp 企業名
Bio-Techne Corporation is a global life sciences company providing tools and bioactive reagents for the research and clinical diagnostic communities. The Company's products assist scientific investigations into biological processes and the nature and progress of specific diseases. The Company, in partnership with Wilson Wolf, is creating products such as media and cytokines that are specifically tailored to G-Rex Bioreactors. Its segments include Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, and tissue biopsy analysis.
企業情報
企業コードTECH
会社名Bio-Techne Corp
上場日Feb 09, 1989
設立日1981
最高経営責任者「CEO」Mr. Kim Kelderman
従業員数3100
証券種類Ordinary Share
決算期末Feb 09
本社所在地614 Mckinley Pl N E
都市MINNEAPOLIS
証券取引所NASDAQ Global Select Consolidated
United States of America
郵便番号55413
電話番号16123792956
ウェブサイトhttps://www.bio-techne.com/
企業コードTECH
上場日Feb 09, 1989
設立日1981
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
60.20K
+24.90%
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
44.86K
+3.37%
Dr. Roeland Nusse, Ph.D.
Dr. Roeland Nusse, Ph.D.
Independent Director
Independent Director
44.56K
+3.39%
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Chief Operating Officer, Director
President, Chief Executive Officer, Chief Operating Officer, Director
37.51K
--
Dr. Joseph D. (Joe) Keegan, Ph.D.
Dr. Joseph D. (Joe) Keegan, Ph.D.
Independent Director
Independent Director
13.77K
+11.88%
Dr. Rupert J. Vessey, Ph.D.
Dr. Rupert J. Vessey, Ph.D.
Independent Director
Independent Director
9.35K
+18.54%
Ms. Julie L. Bushman
Ms. Julie L. Bushman
Independent Director
Independent Director
7.13K
+25.77%
Mr. Shane Bohnen
Mr. Shane Bohnen
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
3.19K
+90.01%
Dr. Matthew F. Mcmanus
Dr. Matthew F. Mcmanus
President - Diagnostics and Genomics Segment
President - Diagnostics and Genomics Segment
2.98K
--
Dr. Judith V. Klimovsky, M.D.
Dr. Judith V. Klimovsky, M.D.
Independent Director
Independent Director
2.14K
+215.00%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
60.20K
+24.90%
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
44.86K
+3.37%
Dr. Roeland Nusse, Ph.D.
Dr. Roeland Nusse, Ph.D.
Independent Director
Independent Director
44.56K
+3.39%
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Chief Operating Officer, Director
President, Chief Executive Officer, Chief Operating Officer, Director
37.51K
--
Dr. Joseph D. (Joe) Keegan, Ph.D.
Dr. Joseph D. (Joe) Keegan, Ph.D.
Independent Director
Independent Director
13.77K
+11.88%
Dr. Rupert J. Vessey, Ph.D.
Dr. Rupert J. Vessey, Ph.D.
Independent Director
Independent Director
9.35K
+18.54%
収益内訳
通貨: USD更新時刻: Sun, Apr 6
通貨: USD更新時刻: Sun, Apr 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Consumables
230.72M
77.67%
Instruments
30.87M
10.39%
Service
27.35M
9.21%
Royalty
8.10M
2.73%
地域別USD
会社名
収益
比率
United States
159.91M
53.83%
EMEA, excluding U.K
70.39M
23.70%
Greater China
24.75M
8.33%
APAC, excluding Greater China
19.01M
6.40%
United Kingdom
13.24M
4.46%
Rest of World
9.73M
3.27%
事業別
地域別
事業別USD
会社名
収益
比率
Consumables
230.72M
77.67%
Instruments
30.87M
10.39%
Service
27.35M
9.21%
Royalty
8.10M
2.73%
株主
更新時刻: Wed, May 14
更新時刻: Wed, May 14
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
11.77%
T. Rowe Price Associates, Inc.
7.11%
BlackRock Institutional Trust Company, N.A.
5.94%
State Street Global Advisors (US)
4.17%
Select Equity Group, L.P.
3.42%
Other
67.59%
株主統計
株主統計
比率
The Vanguard Group, Inc.
11.77%
T. Rowe Price Associates, Inc.
7.11%
BlackRock Institutional Trust Company, N.A.
5.94%
State Street Global Advisors (US)
4.17%
Select Equity Group, L.P.
3.42%
Other
67.59%
種類
株主統計
比率
Investment Advisor/Hedge Fund
48.59%
Investment Advisor
46.42%
Hedge Fund
2.65%
Research Firm
2.30%
Bank and Trust
2.19%
Pension Fund
1.94%
Sovereign Wealth Fund
1.33%
Individual Investor
1.06%
Insurance Company
0.25%
機関投資家保有株
更新時刻: Mon, Jan 20
更新時刻: Mon, Jan 20
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q1
1219
163.12M
103.18%
-2.03M
2024Q4
1233
162.21M
102.61%
-6.39M
2024Q3
1205
159.40M
100.49%
-10.21M
2024Q2
1207
160.52M
101.86%
-12.24M
2024Q1
1216
162.56M
103.40%
-7.57M
2023Q4
1229
159.70M
100.98%
-3.97M
2023Q3
1217
156.41M
98.84%
-7.93M
2023Q2
1213
155.36M
98.68%
-4.04M
2023Q1
1206
153.08M
97.33%
-5.18M
2022Q4
1190
153.16M
97.57%
-6.72M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
18.52M
11.72%
+275.81K
+1.51%
Dec 31, 2024
T. Rowe Price Associates, Inc.
10.43M
6.6%
+1.23M
+13.34%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
9.25M
5.85%
+4.60K
+0.05%
Dec 31, 2024
State Street Global Advisors (US)
6.47M
4.09%
+76.69K
+1.20%
Dec 31, 2024
Select Equity Group, L.P.
2.34M
1.48%
+495.40K
+26.92%
Dec 31, 2024
Geode Capital Management, L.L.C.
4.00M
2.53%
+98.66K
+2.53%
Dec 31, 2024
Atlanta Capital Management Company, L.L.C.
2.95M
1.87%
-40.17K
-1.34%
Dec 31, 2024
Baron Capital Management, Inc.
4.14M
2.62%
-308.56K
-6.94%
Dec 31, 2024
Neuberger Berman, LLC
3.58M
2.27%
+65.69K
+1.87%
Dec 31, 2024
MFS Investment Management
2.52M
1.59%
-59.23K
-2.30%
Dec 31, 2024
詳細を見る
関連ETF
更新時刻: Fri, Jun 6
更新時刻: Fri, Jun 6
銘柄名
比率
Global X Genomics & Biotechnology ETF
3.58%
Invesco Biotechnology & Genome ETF
2.18%
VanEck Biotech ETF
1.59%
Thrivent Small-Mid Cap ESG ETF
1.53%
Hilton Small-MidCap Opportunity ETF
1.5%
Nuveen ESG Mid-Cap Growth ETF
1.37%
Invesco S&P 500 Equal Weight Health Care ETF
1.36%
WisdomTree BioRevolution Fund
1.2%
Tema Monopolies and Oligopolies ETF
1.15%
iShares Health Innovation Active ETF
1.14%
詳細を見る
Global X Genomics & Biotechnology ETF
比率3.58%
Invesco Biotechnology & Genome ETF
比率2.18%
VanEck Biotech ETF
比率1.59%
Thrivent Small-Mid Cap ESG ETF
比率1.53%
Hilton Small-MidCap Opportunity ETF
比率1.5%
Nuveen ESG Mid-Cap Growth ETF
比率1.37%
Invesco S&P 500 Equal Weight Health Care ETF
比率1.36%
WisdomTree BioRevolution Fund
比率1.2%
Tema Monopolies and Oligopolies ETF
比率1.15%
iShares Health Innovation Active ETF
比率1.14%
配当金
過去5年間の配当金総支払額は 249.41M 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
Feb 05, 2025
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Feb 28, 2025 going ex on Feb 14, 2025
Feb 17, 2025
Feb 28, 2025
Feb 14, 2025
Oct 30, 2024
TECH.NB Final Cash Dividend of gross USD 0.08 paid on Nov 22, 2024 going ex on Nov 08, 2024
Nov 11, 2024
Nov 22, 2024
Nov 08, 2024
Aug 07, 2024
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Aug 30, 2024 going ex on Aug 19, 2024
Aug 19, 2024
Aug 30, 2024
Aug 19, 2024
May 01, 2024
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on May 24, 2024 going ex on May 10, 2024
May 13, 2024
May 24, 2024
May 10, 2024
Feb 01, 2024
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Feb 26, 2024 going ex on Feb 09, 2024
Feb 12, 2024
Feb 26, 2024
Feb 09, 2024
Oct 31, 2023
TECH.NB Final Cash Dividend of gross USD 0.08 paid on Nov 24, 2023 going ex on Nov 09, 2023
Nov 10, 2023
Nov 24, 2023
Nov 09, 2023
Aug 08, 2023
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Sep 01, 2023 going ex on Aug 17, 2023
Aug 18, 2023
Sep 01, 2023
Aug 17, 2023
May 03, 2023
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on May 26, 2023 going ex on May 12, 2023
May 15, 2023
May 26, 2023
May 12, 2023
Feb 02, 2023
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Feb 27, 2023 going ex on Feb 10, 2023
Feb 13, 2023
Feb 27, 2023
Feb 10, 2023
Nov 01, 2022
TECH.NB Final Cash Dividend of gross USD 0.32 paid on Nov 28, 2022 going ex on Nov 10, 2022
Nov 14, 2022
Nov 28, 2022
Nov 10, 2022
詳細を見る
株式分割
日付
種類
比率
Nov 01, 2022
Split
1>4
日付
種類
比率
Nov 01, 2022
Split
1>4
tradingkey.logo
tradingkey.logo
当社が提供する日中データはRefinitivより配信されており、同社の利用規約が適用されます。終値データ(過去・現在)についてもRefinitivより提供されています。全ての相場情報は現地取引所時間で表示されます。米国株式のリアルタイム最終取引価格はNasdaqを通じて報告された取引のみを反映しています。日中データは最低15分遅れ、または各取引所の要件に準じて遅延配信されます。
* 当コンテンツ(分析資料・取引戦略等)は第三者プロバイダーであるTrading Centralより提供されており、記載の見解は分析官の独立した評価及び判断に基づくものです。投資家個々の投資目的や財務状況は考慮されておりません。
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。
KeyAI